top of page
Bud hard caps.png

Budesonide Te Arai controlled-release capsules is indicated for the treatment of Crohn's disease. (1)

Budesonide Te Arai is Fully funded from 1 November 2023. (2) 

 

Te Arai BioFarma is proud to be the first generic budesonide 3mg medicine to be funded in New Zealand. 

For product information please visit below

1. Medsafe Datasheet. 2. PHARMAC funding notification 

bottom of page